Patent: 6,228,581
✉ Email this page to a colleague
Summary for Patent: 6,228,581
| Title: | Human intronic and polymorphic SR-BI nucleic acids and uses therefor |
| Abstract: | The present invention is based at least in part on the discovery of the genomic structure of the human SR-BI gene and on the identification of polymorphic regions within the gene. Accordingly, the invention provides nucleic acids having a nucleotide sequence of an allelic variant of an SR-BI gene and nucleic acids having an SR-BI intronic sequence. The invention also provides methods for identifying specific alleles of polymorphic regions of an SR-BI gene, methods for determining whether a subject has or is at risk of developing a disease which is associated with a specific allele of a polymorphic region of an SR-BI gene, and kits for performing such methods. |
| Inventor(s): | Acton; Susan L. (Lexington, MA), Ordovas; Jose M. (Framingham, MA) |
| Assignee: | Millennium Pharmaceuticals, Inc. (Cambridge, MA) Trustees of Tufts College (Boston, MA) |
| Application Number: | 09/031,626 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,228,581
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2017-07-10 |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2017-07-10 | |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2017-07-10 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
